Amolyt Pharma
Benedicte Gagnere is currently the Directeur administratif et financier at Amolyt Pharma, bringing with their a wealth of experience in finance and administration roles. Benedicte has held similar positions in companies such as Althea, NAVYA Group, AplusA, and more. Benedicte's expertise includes managing accounting, finance, HR, legal teams, preparing management accounts, statutory accounts, budgets, and consolidation reporting. Throughout their career, Benedicte has demonstrated strong financial acumen and leadership skills, proving to be a valuable asset to the companies Benedicte has worked for.
Amolyt Pharma
Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders. Its programs include AZP-3601, a parathyroid hormone analog, for the potential treatment of hypoparathyroidism, and AZP-3404, a peptide with a new and unique mechanism of action, that may restore fat and glucose metabolism.